The CRISPR Journal, published by MARY ANN LIEBERT, INC, is a pioneering platform dedicated to advancing the field of genetics and biotechnology through innovative research focused on CRISPR technology and its diverse applications. With an impressive Q1 ranking in both Biotechnology and Genetics for 2023, this journal is positioned among the leading publications in its field, showcasing groundbreaking studies from 2019 to 2024. While currently utilizing a subscription model, the journal's commitment to open science is reflected in its efforts to make high-quality research accessible to researchers, professionals, and students. The CRISPR Journal facilitates the dissemination of knowledge related to genomic editing technologies, fostering collaboration and advancing the understanding of gene manipulation, therapeutic techniques, and agricultural innovations. As a valuable resource for cutting-edge developments in the biochemistry and genetics landscape, this journal is essential for those seeking to stay at the forefront of CRISPR research and applications.

Frontiers in Genome Editing, published by FRONTIERS MEDIA SA, stands at the forefront of genomic research, specializing in the rapidly evolving realm of gene editing technologies. With an enthusiastic commitment to open access since 2020, this journal facilitates unrestricted distribution of cutting-edge research, making significant advancements in biotechnology and genetics accessible to a global audience. Located in Lausanne, Switzerland, Frontiers in Genome Editing publishes high-quality, peer-reviewed articles that contribute to the understanding and application of genome editing tools, such as CRISPR and TALEN, in various biological fields. Notably, as of 2023, the journal holds a prestigious Q1 ranking in Biotechnology and a Q2 ranking in Genetics, underscoring its importance and influence within these disciplines. With robust Scopus rankings, including a notable percentile placement, Frontiers in Genome Editing is an invaluable resource for researchers, professionals, and students dedicated to the promising future of genomic innovation.

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

NUCLEUS-INDIA is a prominent academic journal that delves into the intricate realms of Cell Biology, Genetics, Molecular Biology, and Molecular Medicine. Published by SPRINGER INDIA, this journal has been a reliable source of innovative research since its inception in 2011. With an ISSN of 0029-568X and an E-ISSN of 0976-7975, NUCLEUS-INDIA stands out in the scientific community, functioning as a critical platform for the dissemination of groundbreaking findings and advancements within its fields of study. Despite being categorized in the lower quartiles as of 2023, it remains an important contributor to the literature, providing insights that influence both academic and practical perspectives in genetics and molecular sciences. Researchers, professionals, and students alike can benefit from its diverse array of articles addressing contemporary challenges and innovations. The journal is located at 7th Floor, Vijaya Building, 17, Barakhamba Road, New Delhi 110 001, India, and aims to enhance the scholarly discourse in biology by publishing works that push the boundaries of current understanding.

Microbiology Resource Announcements is a pivotal journal published by the American Society for Microbiology, focusing on disseminating new findings and essential resources in the field of microbiology and related disciplines. With an ISSN of 2576-098X and an E-ISSN of 2576-098X, this journal has been contributing to the scientific community since its inception in 2018 and is set to continue through 2024. Though categorized in the lower quartiles for genetics and molecular biology within its 2023 rankings, it demonstrates a strong presence in immunology, capturing attention with a Q3 rank in that category. The journal is particularly valuable for researchers and professionals seeking to stay abreast of innovative methodologies and significant resource announcements in microbiology, emphasizing practical applications and advancing scientific knowledge. As an open access publication, it champions the free exchange of information, ensuring findings are accessible to a broad audience, thereby fostering collaboration and innovation within the microbiological sciences.

Genome Biology and Evolution, published by Oxford University Press, is a leading open-access journal that has been instrumental in advancing research in the fields of genetics and evolutionary biology since its inception in 2009. With an impressive Q1 ranking in both Ecology, Evolution, Behavior and Systematics and Genetics in 2023, the journal is recognized for its high-quality publications that contribute significantly to the understanding of genomic processes across diverse organisms. As part of its commitment to disseminating impactful research, it is dedicated to fostering interdisciplinary collaboration among scientists and providing a platform for innovative findings. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge within its pages, contributing to ongoing discussions that shape our understanding of evolutionary mechanisms and genomic data interpretation. With its robust access options and a strong commitment to wide dissemination of research, Genome Biology and Evolution remains an essential resource for anyone engaged in the life sciences.

CHROMOSOMA is a prestigious journal dedicated to advancing the field of genetics, published by Springer in Germany. With an ISSN of 0009-5915 and an E-ISSN of 1432-0886, this journal has been a cornerstone in the publishing landscape since its inception in 1939, serving as a critical resource for researchers and professionals interested in the intricacies of chromosomal biology. Although it operates on a subscription basis, the journal's rigorous peer-review process ensures the dissemination of high-quality research findings. With a commendable Q2 ranking in both genetic and clinical genetics categories as of 2023, CHROMOSOMA aims to bridge theoretical concepts with practical applications in medicine and biology. Researchers will appreciate its relevance, as indicated by its Scopus ranks and integration of diverse topics ranging from molecular genetics to clinical implications. By fostering collaboration and knowledge-sharing among scholars, CHROMOSOMA continues to shape the future of genetic research.

Molecular Cytogenetics is a prestigious open-access journal published by BMC, dedicated to advancing the fields of biochemistry, genetics, and molecular biology. Since its inception in 2008, this journal has facilitated prominent research and developments in the cytogenetics domain, featuring innovative studies and reviews that explore the intricate relationship between cellular structures, genetic makeup, and various biological processes. With a robust impact factor and a commendable positioning within Q3 and Q4 categories across multiple relevant disciplines, it provides a vital platform for researchers to disseminate their findings to a global audience. The journal's open-access model ensures that cutting-edge research is readily available to students, professionals, and scholars, promoting free knowledge exchange. Situated in the vibrant landscape of the United Kingdom, Molecular Cytogenetics continues to contribute significantly to scientific progress, solidifying its role as an essential resource for those engaged in the exploration of genetic and cytogenetic inquiry.

FUNCTIONAL & INTEGRATIVE GENOMICS, published by Springer Heidelberg, is a leading journal in the fields of genetics and molecular biology. Established in 2000, it serves as a pivotal platform for advancing our understanding of genomic functionality and integration, making significant contributions to both basic and applied research in genetics. With a robust impact factor and a ranking in the Q3 quartile for Genetics and Q2 for Medicine (Miscellaneous), the journal aims to publish innovative research that explores the relationships between genomic data and biological functions, appealing to a diverse audience of researchers and professionals. Although it operates under a subscription model, the journal's extensive archives remain a valuable resource for academics seeking to stay abreast of the latest findings and methodologies in genomics. As the field evolves, FUNCTIONAL & INTEGRATIVE GENOMICS remains committed to fostering scholarly dialogue and the dissemination of groundbreaking studies that influence future research trajectories.

Mitochondrial DNA Part A, published by Taylor & Francis Ltd, is a distinguished journal dedicated to the exploration of mitochondrial genetics and its implications for health and disease. With an ISSN of 2470-1394 and an E-ISSN of 2470-1408, this journal serves as an open-access platform, promoting the dissemination of high-quality research in the field. Operating from the United Kingdom, it offers a vital resource for researchers and professionals keen to delve into the rapidly evolving landscape of mitochondrial studies. Although currently ranked Q4 in both the Genetics and Molecular Biology categories, the journal continues to be a valuable outlet for emerging findings that could impact our understanding of cellular processes and hereditary conditions. Researchers can access articles and data covering recent advancements from 2016 through 2022, with ongoing contributions expected in 2024. As the field grows, so too does the importance of this journal as a source of knowledge and collaboration for the academic community.